PHARMACOKINETICS OF SULBACTAM AMPICILLIN IN HUMANS AFTER INTRAVENOUS AND INTRAMUSCULAR INJECTION

被引:21
作者
RIPA, S [1 ]
FERRANTE, L [1 ]
PRENNA, M [1 ]
机构
[1] UNIV ANCONA,FAC MED,INST EXPTL & CLIN MED,I-60100 ANCONA,ITALY
关键词
Ampicillin; Pharmacokinetics; Sulbactam;
D O I
10.1159/000238765
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We investigated the pharmacokinetic properties of sulbactam/ampicillin (S/A), after intravenous (0.5/1.0 and 1.0/2.0 g) and intramuscular (0.5/1.0g) coadministration in 10 male subjects. After 1.0/2.0 g intravenous doses of S/A the half-lives (t½) were 1.14 ±0.14/1.09 ±0.16 h. The values for plasma clearance (Clp) were 198.83 ±26.27/250.33 ±39.28 ml/min and the renal clearance (Clr) 173.50 ± 19.66/208.80 ± 26.43 ml/min. The post distributive volumes (Vβ) were 19.67 ± 3.24/23.56 ± 5.76 liters. Similar values were obtained after 0.5/1.0 g of S/A intravenous coinjection. After 0.5/1.0 g intramuscular coadministration the t½β values were 1.26 ± 0.18/1.20 ±0.15 h. The values for Clp were 208.00 ±28.73/243.17 ±33.24 ml/min, for Clr 179.50 ±20.26/202.67 ± 27.61 ml/min and for Vβ 22.27 ±4.12/25.30 ±4.87 liters. The renal clearance of sulbactam is comparable to that of ampicillin and both clearances are greater than the glomerular filtration rate, suggesting active renal tubular secretion of the two drugs. The large volumes of distribution, and the ratio K12/K21 = 0.5 show the extensive distribution of the two drugs into extracellular fluids. The very similar values of the pharmacokinetic parameters of sulbactam and ampicillin confirm that the kinetics of the two drugs closely resemble one another. © 1990 S. Karger AG, Basel.
引用
收藏
页码:185 / 192
页数:8
相关论文
共 15 条
[1]   COMPARATIVE ACTIVITIES OF THE BETA-LACTAMASE INHIBITORS YTR-830, SODIUM CLAVULANATE, AND SULBACTAM COMBINED WITH AMOXICILLIN OR AMPICILLIN [J].
ARONOFF, SC ;
JACOBS, MR ;
JOHENNING, S ;
YAMABE, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 26 (04) :580-582
[2]   HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC ASSAY OF SULBACTAM IN PLASMA, URINE, AND TISSUE [J].
BAWDON, RE ;
MADSEN, PO .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 30 (02) :231-233
[3]   COMPARATIVE PHARMACOKINETICS AND TISSUE PENETRATION OF SULBACTAM AND AMPICILLIN AFTER CONCURRENT INTRAVENOUS ADMINISTRATION [J].
BROWN, RM ;
WISE, R ;
ANDREWS, JM ;
HANCOX, J .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1982, 21 (04) :565-567
[4]   PHARMACOKINETICS OF AMPICILLIN AND ITS PRODRUGS BACAMPICILLIN AND PIVAMPICILLIN IN MAN [J].
EHRNEBO, M ;
NILSSON, SO ;
BOREUS, LO .
JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1979, 7 (05) :429-451
[5]   CP-45,899, A BETA-LACTAMASE INHIBITOR THAT EXTENDS ANTIBACTERIAL SPECTRUM OF BETA-LACTAMS - INITIAL BACTERIOLOGICAL CHARACTERIZATION [J].
ENGLISH, AR ;
RETSEMA, JA ;
GIRARD, AE ;
LYNCH, JE ;
BARTH, WE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1978, 14 (03) :414-419
[7]  
FERRANTE L, 1985, FARMANI USER MANUAL
[8]   PHARMACOKINETICS OF SULBACTAM IN HUMANS [J].
FOULDS, G ;
STANKEWICH, JP ;
MARSHALL, DC ;
OBRIEN, MM ;
HAYES, SL ;
WEIDLER, DJ ;
MCMAHON, FG .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :692-699
[9]  
FOULDS G, 1986, REV INFECT DES S5, V8, P503
[10]  
GIBALDI M, 1982, PHARMACOKINETICS, P1